Skip to product information
1 of 1


Research Tirzepatide 5mg

Research Tirzepatide 5mg

Regular price $74.99 USD
Regular price Sale price $74.99 USD
Sale Sold out

Terzepatide is a peptide indicated for the management of type 2 diabetes mellitus. It is classified as a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist.

Terzepatide is administered via subcutaneous injection and is available in various strengths as prescribed by healthcare professionals. Patients / subjects should follow the dosage instructions provided by their healthcare provider.

The mechanism of action of Terzepatide involves stimulating insulin secretion in a glucose-dependent manner and reducing glucagon secretion, thereby assisting in the regulation of blood sugar levels.

Terzepatide is intended to be used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. It is not indicated for use in individuals with type 1 diabetes or for the treatment of diabetic ketoacidosis.

As with any medication, Terzepatide may cause side effects. Common side effects may include nausea, vomiting, diarrhea, abdominal pain, and decreased appetite. Patients should consult their healthcare provider if they experience any adverse reactions.

Prior to initiating Terzepatide therapy, patients should inform their healthcare provider about all medications, supplements, and medical conditions to mitigate the risk of potential drug interactions or complications.

Terzepatide should only be used under the guidance and supervision of a qualified healthcare professional.

View full details